313 related articles for article (PubMed ID: 15126146)
1. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.
Lai TY; Chan WM; Lam DS
Am J Ophthalmol; 2004 May; 137(5):826-33. PubMed ID: 15126146
[TBL] [Abstract][Full Text] [Related]
2. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.
Imai H; Honda S; Nakanishi Y; Yamamoto H; Tsukahara Y; Negi A
Br J Ophthalmol; 2006 Dec; 90(12):1524-30. PubMed ID: 16825279
[TBL] [Abstract][Full Text] [Related]
3. Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial.
Wu ZH; Lai RY; Yip YW; Chan WM; Lam DS; Lai TY
Retina; 2011; 31(7):1378-86. PubMed ID: 21836413
[TBL] [Abstract][Full Text] [Related]
4. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.
Lai TY; Chan WM; Li H; Lai RY; Liu DT; Lam DS
Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666
[TBL] [Abstract][Full Text] [Related]
5. Transient visual disturbance after photodynamic therapy.
Mennel S; Meyer CH
Am J Ophthalmol; 2005 Apr; 139(4):748-9; author reply 749. PubMed ID: 15808191
[No Abstract] [Full Text] [Related]
6. Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy.
Mackay AM; Brown MC; Hagan RP; Fisher AC; Grierson I; Harding SP
Doc Ophthalmol; 2007 Sep; 115(2):69-76. PubMed ID: 17671804
[TBL] [Abstract][Full Text] [Related]
7. Multifocal electroretinograms in age-related macular degeneration before and after photodynamic therapy.
Kojima M; Yukawa E; Shimoyama K; Nochioka K; Tsujinaka H; Matsuura T
Eur J Ophthalmol; 2012; 22(3):412-6. PubMed ID: 21928263
[TBL] [Abstract][Full Text] [Related]
8. Monitoring retinal function in neovascular maculopathy using multifocal electroretinography - early and long-term correlation with clinical findings.
Jurklies B; Weismann M; Hüsing J; Sutter EE; Bornfeld N
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):244-64. PubMed ID: 11981638
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration.
Tsuchihashi T; Mori K; Peyman G; Shimada Y; Yoneya S
Retina; 2009; 29(10):1450-6. PubMed ID: 19816240
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
Lazic R; Gabric N
Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
[TBL] [Abstract][Full Text] [Related]
11. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation.
Varano M; Parisi V; Tedeschi M; Sciamanna M; Gallinaro G; Capaldo N; Catalano S; Pascarella A
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1453-62. PubMed ID: 15790915
[TBL] [Abstract][Full Text] [Related]
12. The changes of pattern electroretinography at the early stage of photodynamic therapy.
Oner A; Karakucuk S; Mirza E; Erkilic K
Doc Ophthalmol; 2005 Sep; 111(2):107-12. PubMed ID: 16514492
[TBL] [Abstract][Full Text] [Related]
13. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
Isola V; Pece A; Parodi MB
Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867
[TBL] [Abstract][Full Text] [Related]
14. [Testing central retinal function with multifocal electroretinography before and after photodynamic therapy].
Rüther K; Breidenbach K; Schwartz R; Hassenstein A; Richard G
Ophthalmologe; 2003 Jun; 100(6):459-64. PubMed ID: 12820013
[TBL] [Abstract][Full Text] [Related]
15. A preliminary assessment of macular function by MF-ERG in myopic eyes with CNV with complete response to photodynamic therapy.
Moschos MN; Panayotidis D; Moschos MM; Bouros C; Theodossiadis PG; Theodossiadis GP
Eur J Ophthalmol; 2003 Jun; 13(5):461-7. PubMed ID: 12841569
[TBL] [Abstract][Full Text] [Related]
16. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
Pece A; Isola V; Vadalà M; Calori G
Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
[TBL] [Abstract][Full Text] [Related]
20. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
